PharmAthene, Inc. Reports Q3 EPS of $(0.14) Versus Consensus of $(0.17)

by Benzinga Staff
November 11, 2010 4:03 PM | 5 seconds read | Make a Comment
Loading...
Loading...
PharmAthene, Inc.
PIP
reports Q3 EPS of $(0.14) versus Consensus of $(0.17).
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted In: EarningsNewsBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!